Since GAD65 is intracellularly located and is associated with a range of neurological conditions (ataxia, SPS, epilepsy) as well as IDDM, some have argued that anti-GAD65 antibodies have no pathogenic role to play. Here, GAD2 is linked to type 1 diabetes mellitus.